Jon Faiz Kayyem - 28 May 2025 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Role
Director
Signature
/s/ Kelly Deck, as attorney-in-fact to Jon Faiz Kayyem
Issuer symbol
INBX
Transactions as of
28 May 2025
Net transactions value
$0
Form type
4
Filing time
29 May 2025, 16:27:56 UTC
Previous filing
22 May 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kayyem Jon Faiz Director C/O INHIBRX BIOSCIENCES, INC., 11025 NORTH TORREY PINES ROAD, SUITE 140, LA JOLLA /s/ Kelly Deck, as attorney-in-fact to Jon Faiz Kayyem 29 May 2025 0001366268

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Award $0 +15,000 $0.000000 15,000 28 May 2025 Common Stock 15,000 $12.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option will be fully exercisable on May 28, 2026, subject to the reporting person's continued service through such date.